Results 111 to 114 of about 177,998 (114)

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

Investigational New Drugs, 2005
exaly  

The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol

European Journal of Pharmacology, 1997
exaly  

A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas

Investigational New Drugs, 2008
exaly  

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

Psychopharmacology, 1995
exaly